Pharma patent litigation used to be a $50M event.
Now, in many cases, it’s becoming a $5M event.
That’s not a slogan—it’s the direction of travel, and it’s showing up in the way companies are budgeting, structuring defenses, and managing risk across th…

PBMs don’t just “manage formularies.” They shape the economics of every branded drug in the U.S.—often long before a patient ever sees a prescription.
And if you’re a pharma executive still treating formularies and rebates like back-office mechanics, y…

Mark Cuban’s “cost-plus” pricing isn’t just a new way to buy medicine—it’s a direct challenge to the patent playbook that has quietly shaped U.S. drug pricing for decades.
For years, the industry’s story has been consistent: patents protect innovation,…

Should you file a provisional patent for your drug invention? The honest answer.
Most founders in biotech don’t lose sleep over the science—they lose sleep over the clock.
Because in drug development, time isn’t just money. It’s leverage. It’s investor…

Don’t Wait for the Patent Cliff. Build Supply-Chain Resilience Years Before Drug Patent Expiration.
The patent cliff isn’t a cliff. It’s a countdown.
And in pharma, the countdown starts long before the last patent expires—often years before. Yet many c…

The 180-Day FDA Exclusivity Race Isn’t a Sprint—It’s a Legal & Commercial War Game
In generic and biosimilar development, everyone talks about the “180-day exclusivity” like it’s a finish line. But the truth is harsher: it’s a moving target shaped …

Pharma is still missing the point of the PBM endgame.
Mark Cuban didn’t invent the problem—he just named it clearly: pharmacy benefit managers (PBMs) sit between patients and medicines, and the incentives they’re built on often don’t align with patient…

What year did the FDA approve Keytruda (pembrolizumab)? Keytruda (pembrolizumab) first received FDA approval in 2014. [1]… https://www.Drugchatter.com/chat/49405/keytruda’s-fda-approval-can-you-name-the-year/

What year did the FDA approve Keytruda (pembrolizumab)? Keytruda (pembrolizumab) first received FDA approval in 2014. [1]… https://www.Drugchatter.com/chat/49405/keytruda’s-fda-approval-can-you-name-the-year/

What year did the FDA approve Keytruda (pembrolizumab)? Keytruda (pembrolizumab) first received FDA approval in 2014. [1]… https://www.Drugchatter.com/chat/49405/keytruda’s-fda-approval-can-you-name-the-year/